BHC - Bausch Health Companies Inc.

NYSE - NYSE Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
8,498,000
8,380,000
8,724,000
9,674,000
10,446,500
Cost of Revenue
2,317,000
2,351,000
2,548,000
2,611,000
2,584,700
Gross Profit
6,181,000
6,029,000
6,176,000
7,063,000
7,861,800
Operating Expenses
Research Development
478,000
414,000
366,000
455,000
334,400
Selling General and Administrative
2,512,000
2,473,000
2,582,000
2,810,000
2,699,800
Total Operating Expenses
4,949,000
5,531,000
5,639,000
5,956,000
5,708,600
Operating Income or Loss
1,232,000
498,000
537,000
1,107,000
2,153,200
Interest Expense
1,635,000
1,685,000
1,840,000
1,836,000
1,563,200
Total Other Income/Expenses Net
-401,000
-2,978,000
-450,000
-1,714,000
-748,600
Income Before Tax
-793,000
-4,154,000
-1,741,000
-2,435,000
-155,300
Income Tax Expense
-185,000
-10,000
-4,145,000
-27,000
132,500
Income from Continuing Operations
-608,000
-4,144,000
2,404,000
-2,408,000
-287,800
Net Income
-616,000
-4,148,000
2,404,000
-2,409,000
-291,700
Net Income available to common shareholders
-616,000
-4,148,000
2,404,000
-2,409,000
-291,700
Reported EPS
Basic
-
-11.86
6.86
-6.94
-
Diluted
-
-11.86
6.83
-6.94
-
Weighted average shares outstanding
Basic
-
349,871
350,200
347,300
-
Diluted
-
349,871
351,800
347,300
-
EBITDA
-
350,000
2,957,000
2,267,000
4,035,400